LeonaBio (LONA) Non-Current Assets (2019 - 2026)

LeonaBio (LONA) has 8 years of Non-Current Assets data on file, last reported at $2.4 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $2.4 million, down 34.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.4 million (down 30.35% YoY), and the FY2025 annual result was $2.7 million, down 31.62% from the prior year.
• Non-Current Assets retreated to $2.4 million in Q1 2026 per LONA's latest filing, from $2.7 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $50.6 million in Q4 2022 and troughed at $2.4 million in Q1 2026.
• A 5-year average of $16.2 million and a median of $4.8 million in 2024 frame the typical range for Non-Current Assets.
• On a YoY basis, Non-Current Assets climbed as much as 9.06% in 2023 and fell as far as 89.1% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $50.6 million in 2022, then plunged by 89.1% to $5.5 million in 2023, then declined by 28.61% to $3.9 million in 2024, then plunged by 31.62% to $2.7 million in 2025, then slipped by 11.33% to $2.4 million in 2026.
• Business Quant data shows LONA's Non-Current Assets at $2.4 million in Q1 2026, $2.7 million in Q4 2025, and $3.0 million in Q3 2025.